Regulators Tell Illumina to Unwind GRAIL Deal Investing News admin April 3, 2023 0 77 1 minute read Shares of Ilumina (ILMN) dropped as the Federal Trade Commission (FTC) ordered the biotech firm to unwind its purchase of cancer test provider GRAIL.